Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-10 5:01 pm Purchase | 2021-12-31 | 13G | Edap Tms S.a. EDAP | Soleus Capital Master Fund, L.P. | 3,148,609 9.400% | 1,324,043 (+72.57%) | Filing History |
| 2022-02-10 5:01 pm Purchase | 2021-12-31 | 13G | Theratechnologies Inc. THTX | Soleus Capital Master Fund, L.P. | 2,310,521 9.600% | 454,175 (+24.47%) | Filing History |
| 2022-02-10 5:01 pm Purchase | 2021-12-31 | 13G | Apollo Endosurgery, Inc. APEN | Soleus Capital Master Fund, L.P. | 2,295,100 5.800% | 209,603 (+10.05%) | Filing History |
| 2022-01-27 4:30 pm Purchase | 2022-01-24 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Soleus Capital Master Fund, L.P. | 48,561 5.400% | 48,561 (New Position) | Filing History |
| 2021-12-20 5:01 pm Purchase | 2021-12-14 | 13G | Apollo Endosurgery, Inc. APEN | Soleus Capital Master Fund, L.P. | 2,085,497 5.300% | 2,085,497 (New Position) | Filing History |
| 2021-04-27 5:41 pm Purchase | 2021-04-23 | 13G | Edap Tms S.a. EDAP | Soleus Capital Master Fund, L.P. | 1,824,566 5.500% | 1,824,566 (New Position) | Filing History |
| 2021-02-23 4:11 pm Purchase | 2021-01-19 | 13G | Theratechnologies Inc. THTX | Soleus Capital Master Fund, L.P. | 1,856,346 7.800% | 1,856,346 (New Position) | Filing History |